Companies / Convergent Genomics
Convergent Genomics
United States
Convergent Genomics is a genomic diagnostic company that develops a non-invasive genomic urine test to detect and predict the risk of urothelial cancer
Convergent Genomics, based in United States, has 2 investors on file, among them Civilization Ventures and Springboard. Its site was last checked 6 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Accelerator |
More from Civilization Ventures
59 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (73%), AI & Machine Learning (6%), Industrial & Manufacturing (5%).
See Civilization Ventures' full profile · Who invests alongside it
More from Springboard
445 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (44%), E-commerce & Marketplaces (10%), AI & Machine Learning (10%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Convergent Genomics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Civilization Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/convergentgenomics.com/investors
# also
GET /v1/companies/convergentgenomics.com
GET /v1/companies/convergentgenomics.com/news